Erythropoietin structure-function relationships: high degree of sequence homology among mammals

  • D Wen
    Hematology/Oncology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • JP Boissel
    Hematology/Oncology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • TE Tracy
    Hematology/Oncology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • RH Gruninger
    Hematology/Oncology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • LS Mulcahy
    Hematology/Oncology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • J Czelusniak
    Hematology/Oncology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • M Goodman
    Hematology/Oncology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • HF Bunn
    Hematology/Oncology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.

書誌事項

公開日
1993-09-01
DOI
  • 10.1182/blood.v82.5.1507.bloodjournal8251507
公開者
American Society of Hematology

この論文をさがす

説明

<jats:p>To investigate structure-function relationships of erythropoietin (Epo), we have obtained cDNA sequences that encode the mature Epo protein of a variety of mammals. A first set of primers, corresponding to conserved nucleotide sequences between mouse and human DNAs, allowed us to amplify by polymerase chain reaction (PCR) intron 1/exon 2 fragments from genomic DNA of the hamster, cat, lion, dog, horse, sheep, dolphin, and pig. Sequencing of these fragments permitted the design of a second generation of species-specific primers. RNA was prepared from anemic kidneys and reverse-transcribed. Using our battery of species-specific 5′ primers, we were able to successfully PCR- amplify Epo cDNA from Rhesus monkey, rat, sheep, dog, cat, and pig. Deduced amino acid sequences of mature Epo proteins from these animals, in combination with known sequences for human, Cynomolgus monkey, and mouse, showed a high degree of homology, which explains the biologic and immunological cross-reactivity that has been observed in a number of species. Human Epo is 91% identical to monkey Epo, 85% to cat and dog Epo, and 80% to 82% to pig, sheep, mouse, and rat Epos. There was full conservation of (1) the disulfide bridge linking the NH2 and COOH termini; (2) N-glycosylation sites; and (3) predicted amphipathic alpha- helices. In contrast, the short disulfide bridge (C29/C33 in humans) is not invariant. Cys33 was replaced by a Pro in rodents. Most of the amino acid replacements were conservative. The C-terminal part of the loop between the C and D helices showed the most variation, with several amino acid substitutions, deletions, and/or insertions. Calculations of maximum parsimony for intron 1/exon 2 sequences as well as coding sequences enabled the construction of cladograms that are in good agreement with known phylogenetic relationships.</jats:p>

収録刊行物

  • Blood

    Blood 82 (5), 1507-1516, 1993-09-01

    American Society of Hematology

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ